Pulmonary Lobectomy After COVID-19

Alberto Testori, Gianluca Perroni, Emanuele Voulaz, Alessandro Crepaldi, Marco Alloisio, Alberto Testori, Gianluca Perroni, Emanuele Voulaz, Alessandro Crepaldi, Marco Alloisio

Abstract

Concomitant coronavirus disease 19 (COVID-19) is a major risk factor for complications in any type of surgical procedure, especially in thoracic surgery, were the primary organ involved, the lung, is manipulated to perform parenchymal resection. However, it is not clear whether previous infection from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may lead to increased morbidity and mortality for subsequent procedures once radiologic resolution is achieved. We report a young patient with lung cancer who successfully underwent a right upper lobectomy for primary adenocarcinoma by video-assisted thoracoscopic surgery with no complication in the early postoperative phase.

Copyright © 2021 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Figures

Figure 1
Figure 1
Chest computed tomography scans (left) before and (right) 30 days after coronavirus disease 2019 (COVID-19). An almost complete resolution of peripheral opacities is visible.
Figure 2
Figure 2
Initial dissection during lobectomy. From left to right: superior pulmonary vein (SPV), right upper lobe (RUL), Azygos vein (AV), and superior vena cava (SVC). The arrows indicate adhesions between lung and hilar structures.
Figure 3
Figure 3
After closure and section of the superior pulmonary artery (SPA) and superior pulmonary vein (SPV), an enlarged lymph node (LN) blocking the passage to right upper bronchus is present.

References

    1. Testori A., Alloisio M., Errico V., Perroni G., Gatzemeier W., Tinterri C. Extraordinary emergency measures set up by a breast unit to prevent COVID-19: report of our experience. Breast J. 2020;26:1611–1612.
    1. Tian S., Hu W., Niu L., Liu H., Xu H., Xiao S.Y. Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer. J Thorac Oncol. 2020;15:700–704.
    1. Pan F., Ye T., Sun P., Zhang G.J. Time course of lung changes at chest CT during recovery from coronavirus disease 2019 (COVID-19) Radiology. 2020;295:715–721.
    1. Lei S., Jiang F., Su W., Zhang G.J. The clinical dynamics of 18 cases of COVID-19 outside of Wuhan. Eur Respir J. 2020;55:2000398.
    1. BTS recommendations to respiratory physicians for organising the care of patients with lung cancer. The Lung Cancer Working Party of the British Thoracic Society Standards of Care Committee. Thorax. 1998;53(Suppl 1):S1–S8.
    1. Lim E., Baldwin D., Beckles M. Guidelines on the radical management of patients with lung cancer. Thorax. 2010;65(Suppl 3):iii1–iii27.
    1. Mo X., Jian W., Su Z. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. Eur Respir J. 2020;55:2001217.
    1. Ackermann M., Verleden S.E., Kuehnel M. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med. 2020;383:120–128.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe